Thirty years after identification of HIV, the AIDS epidemic continues with an estimated 34 million individuals currently infected worldwide and 2.5 million new infections each year. Research to prevent and treat HIV infection has grown increasingly sophisticated and the analytic challenges have become correspondingly complex. This application is intended to address timely and important statistical issues in HIV/AIDS research. In particular, novel statistical methods will be developed for (i) analysis of data from studies of pre-exposure prophylaxis (PrEP), (ii) optimal design and analysis of studies with complex sampling and observation schemes, and (iii) optimal design of pooling studies. First, statistical methods are proposed that address key challenges in PrEP studies, namely, inferring drug efficacy in the face of incomplete adherence, combining disparate sources of information to estimate adherence and summarizing adherence patterns. The approaches include causal modeling, Bayesian synthesis of information and functional data analysis. The proposed methods have the potential to provide clarity in a field which is hindered by disparate trial results. Second, becaue HIV studies often utilize expensive tests and assays, the proposed research will explore optimal sampling designs and efficient semiparametric and nonparametric methods for studies that use such two-phase or multi-phase sampling. The problems of multi-phase sampling and competing risks in the context of interval censored data will also be studied. These methods will provide critical guidance for optimizing the use of resources and minimizing costs in studies that utilize expensive assays. Finally, the proposed research will investigate statistical methods for the analysis of pooled data with specific applications to epitope mapping and monitoring for virologic failure in resource constrained settings. The former is a critical component of HIV vaccine development and the latter has the potential to greatly improve health care of HIV-infected individuals in developing countries. The proposed research reflects the extensive and ongoing involvement of the investigators in the field of HIV/AIDS research. The statistical problems addressed are motivated by applications in key areas of HIV research. The solutions outlined are highly innovative and directly applicable to current scientific research in vaccine development, trials of pre-exposure prophylaxis, and other HIV/AIDS trials and studies.
| Fleming, Thomas R; Ellenberg, Susan S; DeMets, David L (2018) Data Monitoring Committees: Current issues. Clin Trials 15:321-328 |
| Chung, Yunro; Ivanova, Anastasia; Hudgens, Michael G et al. (2018) Partial likelihood estimation of isotonic proportional hazards models. Biometrika 105:133-148 |
| Wakefield, Jon; Fuglstad, Geir-Arne; Riebler, Andrea et al. (2018) Estimating under-five mortality in space and time in a developing world context. Stat Methods Med Res :962280218767988 |
| Halloran, M Elizabeth; Auranen, Kari; Baird, Sarah et al. (2017) Simulations for designing and interpreting intervention trials in infectious diseases. BMC Med 15:223 |
| Jiang, Runchao; Lu, Wenbin; Song, Rui et al. (2017) DOUBLY ROBUST ESTIMATION OF OPTIMAL TREATMENT REGIMES FOR SURVIVAL DATA-WITH APPLICATION TO AN HIV/AIDS STUDY. Ann Appl Stat 11:1763-1786 |
| Fleming, Thomas R; DeMets, David L; Roe, Matthew T et al. (2017) Rejoinder. Clin Trials 14:126-127 |
| Mao, Lu; Lin, D Y (2017) Efficient Estimation of Semiparametric Transformation Models for the Cumulative Incidence of Competing Risks. J R Stat Soc Series B Stat Methodol 79:573-587 |
| Fleming, Thomas R; Demets, David L; McShane, Lisa M (2017) Discussion: The role, position, and function of the FDA-The past, present, and future. Biostatistics 18:417-421 |
| Zeng, Donglin; Gao, Fei; Lin, D Y (2017) Maximum likelihood estimation for semiparametric regression models with multivariate interval-censored data. Biometrika 104:505-525 |
| Li, Quefeng; Yu, Menggang; Wang, Sijian (2017) A Statistical Framework for Pathway and Gene Identification from Integrative Analysis. J Multivar Anal 156:1-17 |
Showing the most recent 10 out of 129 publications
